Evidence map›Paper›PMID 31131640›Full record

Trial reportIntegrative cancer therapies

Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.

Mary Lou Galantino, Robyn Tiger, Jennifer Brooks, Shera Jang, Kim Wilson

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03786055 (Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors), which is not on this map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03786055 nacompletednot on this map

Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors

TypeinterventionalSponsorStockton UniversityRan2018 to 2019Enrolled18ConditionsCancer Survivor, Pain, Chemotherapy Induced Peripheral Neuropathy, FunctionArmsSomatic Yoga and Meditation (SYM)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mary Lou Galantino1 School of Health Sciences, Doctor of Physical Therapy Program, Stockton University, Galloway, NJ, USA.
Robyn Tiger4 Yoga Heals 4 Life, Southern NJ, USA.
Jennifer Brooks5 Bacharach Institute for Rehabilitation, Pomona, NJ, USA.
Shera Jang1 School of Health Sciences, Doctor of Physical Therapy Program, Stockton University, Galloway, NJ, USA.
Kim Wilson1 School of Health Sciences, Doctor of Physical Therapy Program, Stockton University, Galloway, NJ, USA.
Stockton University · USBacharach Institute for Rehabilitation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChemotherapy-induced peripheral neuropathy (CIPN) syndrome causes significant pain as an adverse effect of treatment, with few nonpharmacological interventions tested. A somatic yoga and meditation (SYM) intervention on functional outcomes and quality of life (QOL) was investigated. DESIGN AND

methodsIndividuals diagnosed with CIPN were enrolled in an open-label, single-arm, mixed-methods feasibility trial. PARTICIPANTS AND

settingIn an outpatient rehabilitation center, ten participants with median age 64.4 years (47-81) attended 61% of the sessions with no adverse events.

interventionSYM twice a week for 8 weeks for 1.5 hours, with home program and journaling.

main outcome measuresPrimary functional outcomes included Sit and Reach (SR), Functional Reach (FR), and Timed Up and Go (TUG). Self-reported Patient Neurotoxicity Questionnaire (PNQ) and Functional Assessment of Cancer Therapy-Neurotoxicity (FACT-GOG-NTX) were secondary CIPN outcomes. Biomarkers included salivary cortisol (stress) and bioesthesiometer (vibration).

resultsQuantitative findings. Significant improvements were found in flexibility (SR; P = .006); balance (FR; P = .001) and fall risk (TUG; P = .004). PNQ improved significantly ( P = .003) with other measures improving non-significantly. Qualitative findings. Five themes emerged: (1) vacillation of CIPN pain perception over time; (2) transferability of skills to daily activities; (3) improvement in physical function; (4) perceived relaxation as an effect of SYM; and (5) group engagement provided a social context for not feeling isolated with CIPN.

conclusionPreliminary data suggest SYM may improve QOL, flexibility, and balance in cancer survivors with CIPN, with a fully powered randomized controlled trial indicated.

trial registrationNCT03786055.

Indexed as

Accidental FallsAntineoplastic AgentsCancer SurvivorsFemaleHumansMaleMeditationMiddle AgedPeripheral Nervous System DiseasesQuality of LifeSurveys and QuestionnairesYogaAntineoplastic Agentscancer survivorshipfall riskfunctionneuropathyquality of lifesomatic yoga

Identifiers

PMID31131640
PMCPMC6537287
OpenAlexW2944822742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.